PGS involves the biopsy of a few cells from an embryo, typically at the blastocyst stage. These cells are then analyzed for chromosomal abnormalities. The embryos that are found to be chromosomally normal are selected for transfer to the uterus. This screening can detect issues such as aneuploidy, where there are an abnormal number of chromosomes.
